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ORIGINAL ARTICLES
Studies have shown that operative thrombecto-
my may provide long-term iliac venous patency rates
of about 80%, especially when combined with con-
struction of an inguinal arteriovenous fistula.1-4
However, for a large number of patients thrombec-
tomy is incomplete or impossible, or early rethrom-
bosis occurs. Iliofemoral venous thrombosis occurs
much more frequently on the left side than on the
right. The cause is believed to be lifelong pulsatile
compression of the left common iliac vein between
the overlying right common iliac artery and the
promontory.5,6 By causing fibrous strictures and
web- or spur-like stenoses of the left common iliac
vein, this iliac compression syndrome7 might be
responsible for the frequent difficulties in restoring
venous patency by means of thrombectomy alone.
The purpose of this study was to determine the fre-
quency of iliac venous spurs in left iliofemoral
venous thrombosis and to report the results of inter-
vention in venous spurs after transfemoral venous
thrombectomy. 
METHODS 
In 1995, we began a prospective study on inter-
vention in venous spurs after transfemoral venous
thrombectomy. Results were compared ( c 2 test)
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with those for a group of patients who underwent
consecutive operations between 1990 and 1994
without immediate management of spurs. Primary
and secondary patency rates of implanted stents
were calculated according to the life-table method.8
Indications for venous thrombectomy were stan-
dardized throughout the period. Patients older than
60 years underwent operations only if they suffered
from phlegmasia cerulea dolens. Clinical thrombus
age had to be less than 10 days, unless unsuccessful
thrombolytic therapy (3 patients) or recurrent pul-
monary embolism (6 patients) preceded presenta-
tion. All patients had iliac thrombi at phlebography.
Tumor compression of the iliac veins was ruled out
by means of preoperative sonography or computed
tomography. All patients underwent transfemoral
venous thrombectomy with construction of an
inguinal prosthetic (5 mm expanded polytetrafluo-
roethyelene) arteriovenous fistula. Additional
transperitoneal caval thrombectomy was performed
on patients with floating caval thrombi. In all
patients, the morphologic features of the iliac vein
after transfemoral Fogarty thrombectomy were
documented by means of intraoperative phlebogra-
phy. Between 1990 and 1994, venous spurs detect-
ed during thrombectomy were left untreated. 
Since 1995, angioplasty and stenting of venous
spurs have been added to our routine procedure. For
the first three patients, Palmaz stents (Cordis Corp,
Miami, Fl) were implanted on the first postoperative
day through a transjugular approach. The method and
immediate results have been reported elsewhere.9 The
other patients underwent intraoperative implantation
of self-expandable stents. Depending on the surgeons’
preferences, a Wallstent endoprosthesis (Schneider,
Minneapolis, Minn) or nitinol stent was used. After
thrombectomy and intraoperative phlebography (Fig
1), a 10F sheath was introduced through the inguinal
venotomy. Stents were implanted under road-mapping
control with a mobile digital subtraction angiography
unit. Great care was taken to avoid bridging of the left
internal iliac vein and stent protrusion into the inferior
vena cava (Fig 2). All stents were dilated to achieve
complete opening within the fibrous strictures of the
common iliac veins (Fig 3).
All patients underwent perioperative full-dose
heparin anticoagulation (partial thromboplastin time
60 to 90 seconds), and the medication was switched
to vitamin K antagonists for at least 1 year.
Arteriovenous fistulas were routinely closed after
arteriovenography 3 months after the operation.
(Most of the patients underwent surgical ligation of
the fistula, and interventional embolization recently
has been performed successfully on six patients.)
Thereafter all patients were seen every 3 months for
clinical follow-up examinations and duplex sonogra-
Fig. 1. Intraoperative phlebogram of a 45-year-old
woman. After transfemoral thrombectomy for iliofemoral
venous thrombosis, persistent, complete occlusion of the
left common iliac vein was caused by iliac compression
syndrome. Huge presacral collateral blood vessel indicates
chronic venous obstruction.
Fig. 2. Intraoperative phlebogram of a 45-year-old
woman. A guide wire was manipulated through the occlu-
sion. After implantation of a Wallstent endoprosthesis (12
· 40 mm), there is still high-grade stenosis of the left com-
mon iliac vein. 
JOURNAL OF VASCULAR SURGERY
494 Mickley et al September 1998
phy. During March and April 1997, and after giving
informed consent, patients with iliac venous stents
underwent ascending phlebography or computed
tomography with three-dimensional reconstruction
for exact delineation of stent configuration and
eventual restenosis. 
RESULTS
During the study period, four nonfatal pul-
monary embolisms were encountered (5%). One
occurred during the operation at wound closure.
Despite acute severe right heart failure, the patient
was successfully resuscitated and later left the hospi-
tal without adverse sequelae. Minor pulmonary
embolism was diagnosed among three patients on
postoperative days 1 to 3. They had acute dyspnea
and inspiratory pain without signs of cardiac shock.
The diagnosis was confirmed by means of pul-
monary perfusion scintigraphy. None of the pul-
monary embolisms occurred among patients with
stents.
From 1990 through 1994, 50 consecutive trans-
femoral venous thrombectomies with construction
of an arteriovenous fistula were performed. Forty-
one patients had left iliofemoral venous thrombosis.
Among 22 patients (54% of those with left-sided
thrombosis) an iliac venous spur was diagnosed dur-
ing thrombectomy and left untreated. Sixteen (72%)
of these iliac veins (39% of all instances of left-sided
thrombosis) reoccluded during the follow-up peri-
od. There was one reocclusion of a right iliac vein
and none of a left vein without spur. All rethrom-
boses occurred before scheduled closure of the arte-
riovenous fistula 3 months after the operation. From
1995 through 1996, 27 consecutive transfemoral
venous thrombectomies with construction of an
arteriovenous fistula were performed. Venous spurs
were found among 8 (40%) of 20 instances of left
iliofemoral thrombosis. All spurs were managed by
means of immediate stent implantation. A total of
12 stents were implanted. Palmaz stents were used
to treat 3 patients (6 stents), nitinol stents to treat 3
Fig. 3. Intraoperative phlebogram of a 45-year-old woman. Complete restoration of venous
patency was achieved by means of high-pressure balloon dilation of the stented segment.
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patients (4 stents), and a Wallstent endoprosthesis to
treat 2 patients. There was only one instance of sin-
gle acute rethrombosis among this group of
patients, and it was caused by intraoperative mis-
placement of the stent. Patency could not be
restored despite implantation of a second stent. No
other procedure-related complications were record-
ed. Three months after the operation, symptomatic
restenosis (leg swelling) was detected in another
stent. After successful percutaneous dilation, the
patient had no symptoms for 18 months. Both com-
plications occurred in nitinol stents. All other stents
remained widely open throughout the study period
(4.5 to 30 months). There was no reocclusion of a
right iliac vein, but there were two instances of reoc-
clusion in left iliac veins without spur.
The primary 2-year patency rate (Fig 4) of
implanted stents was 73%. The secondary patency
rate was 82%. Iliofemoral rethrombosis was signifi-
cantly less frequent after stent implantation for iliac
venous spurs than when spurs were left untreated
(72% versus 13%; c 2 test P < .01). Rethrombosis in
the right iliac veins and in the left iliac veins without
documented spurs occurred in 6% of instances,
which was not significantly different from the reoc-
clusion rate after stent implantation (c 2 test P = .68).
DISCUSSION
As early as 1906, McMurrich10 observed valve-
like strictures of the left iliac vein causing iliofemoral
venous thrombosis.11 He suggested a congenital ori-
gin of the lesion. May and Thurner5 in 1956
assumed that permanent pulsation of the overlying
right common iliac artery might induce reactive pro-
liferation of venous wall cells and give rise to web- or
spur-like stenosis. They reported that venous spurs
(as they called them) occurred in about 20% of
healthy adults. This frequency was later confirmed
by Salomonowitz and Gottlob6 in another autopsy
study. Little is known, however, about frequency
and importance of this phenomenon in acute venous
thrombosis and chronic venous insufficiency.
Having in mind the great number of asymptomatic
venous spurs among healthy adults without a histo-
ry of venous disease, we were not surprised to find
iliac compression syndromes present in 49% of
instances of left-sided thrombosis. By means of
venous endoscopy after thrombectomy, Vollmar and
Hutschenreiter12 detected venous spurs in 50% of all
instances of left-sided thrombosis. Juhan et al4 by
means of completion venography found a 62%
prevalence of iliac spurs in a series of 50 left
iliofemoral thrombectomies.
Today there are several surgical options to cope
with these lesions7,13-18 (Table I). Some authors
prefer the direct approach by patch venoplasty com-
bined with retropositioning of the artery or tissue
slings or flaps that elevate the artery. These opera-
tions necessitate median laparotomy and extensive
dissection of blood vessels or even division and
reanastomosis. Venovenous crossover bypasses are
less invasive. With a crossover bypass, however, the
surgeon has to operate on at least one as yet undis-
eased vein, which could lead to the well-known
sequelae and complications of venous operations.
The great diversity of methods recommended for
correction of the iliac compression syndrome indi-
cates therapeutic insecurity rather than a generally
satisfactory outcome. Only a few long-term studies
have been performed and these have small numbers
of surgical patients. Depending on authors and pro-
cedures, patency rates between 0% and 70% are
given. The better rates are for the more invasive
options, that is, arterial retropositioning and pros-
thetic bypass.19-23
The simple structure of most venous spurs and
the great potential of modern endovascular treat-
ment make it appealing to look for less invasive alter-
Table I. Surgical options for the treatment of
venous spurs.
Author Year Method
Palma and Esperon13 1960 Saphenofemoral 
crossover
Calnan et al14 1964 Arterial 
retropositioning
Cockett and Thomas7 1965 Peritoneal flap
Rigas et al15 1970 Fascia lata sling
Trimble et al16 1972 Prosthetic bridging
Pokrovsky and Klioner17 1977 Aortic elevation
Vollmar and Hutschenreiter12 1989 Ilioiliac 
crossover bypass
Fig. 4. Cumulative primary (open boxes) and secondary
(closed boxes) patency rates of implanted stents.
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natives to surgical procedures. Successful percuta-
neous transluminal angioplasty (PTA) of venous
spurs diagnosed after thrombectomy or thromboly-
sis have been described in case reports24 and small
series25,26 since 1991. 
After we27 and other authors25 showed that PTA
of central venous stenosis had an unacceptably high
recurrence rate, we combined PTA with stent
implantation. In 1995 we began routinely to stent
venous spurs immediately after transfemoral venous
thrombectomy. Our first three patients were treated
on the first postoperative day by means of a trans-
jugular approach.9 With a mobile digital subtraction
angiography unit, we performed intraoperative stent
implantation thus sparing the patients another inva-
sive procedure. Misplacement of a nitinol stent in
one patient caused acute reocclusion of the common
iliac vein despite immediate implantation of a second
stent. Misplacement was caused by insufficient stent
visualization in this adipose patient. No other intra-
operative complications were encountered. Three
months after thrombectomy, restenosis within stent
caused recurrent leg swelling in another patient.
Transfemoral PTA was performed by means of a
crossover technique; after 18 months there was no
recurrent stenosis. When restenosis is classified as
stent failure, the cumulative primary patency rate for
all 12 implanted stents was 73% at 1 and 2 years.
When successful redilation at 3 months was includ-
ed, the secondary patency rate was 82% at 1 and 2
years. Our results compared favorably with those of
the surgical series cited earlier.19-23
To our knowledge, this is the first study on peri-
operative stent implantation for the management of
iliac compression syndrome causing iliofemoral
venous thrombosis. Some authors, however, have
reported on stenting of venous spurs eventually
detected during fibrinolytic therapy. The largest
series is that of Buelens et al,28 who reported suc-
cessful treatment of six patients with Wallstent endo-
prostheses. Semba and Dake,29 in their collective
series of 27 limbs with acute or chronic iliofemoral
thrombosis, mention two patients with May-
Thurner syndrome. Both had chronic occlusion of
the common iliac veins. In one of them, the occlu-
sion could be passed with a guide wire, and after
catheter-directed thrombolysis, a Palmaz stent was
implanted. In a later publication on 41 limbs, the
same authors30 presented phlebograms of a 33-year-
old female patient with successful thrombolysis of
acute thrombosis of the left external iliac vein and
persistent high-grade common iliac venous stenosis
suggestive of venous spur. By means of implantation
of two Wallstent endoprostheses, complete restora-
tion of the venous lumen was achieved. The stents
remained widely open until the last follow-up exam-
ination, at 6 months. In the treatment of an 18-year-
old male patient, Åkesson et al,31 after reopening a
chronic occlusion of a left external iliac vein by
means of Wallstent implantation and after addition-
al local fibrinolysis, detected a venous spur and man-
aged it with a Palmaz stent. Nineteen months after
the procedure, phlebography showed complete
patency of the stented veins. Berger et al32 diag-
nosed iliac compression syndrome on computed
tomographic scans obtained for acute iliac venous
occlusion in a 51-year-old man. Two Palmaz stents
were implanted after successful catheter-directed
thrombolysis. Patency was demonstrated at a 6-
month follow-up phlebographic examination.
Wallstent endoprostheses seem to have consider-
able advantages over the other stent models we used.
Unlike Palmaz stents, they are flexible and allow
nontraumatic manipulation within curved vessel seg-
ments. In comparison with commercially available
nitinol stents, their greater radiodensity guarantees
easy visualization in adipose patients, even with
mobile digital subtraction angiography in the intra-
operative setting. Although Wallstent endoprosthe-
ses shorten about 20% to 30% during expansion, the
end of the stent distal to the surgeon can be posi-
tioned accurately. Stent protrusion into the inferior
vena cava can be safely avoided as long as the stent is
implanted from the groin.
Venous spurs that cause marked luminal narrowing
of the common iliac vein are found among about 20%
of adults without symptoms and about 50% of adults
with left iliac venous thrombosis. Intraoperative PTA
and stent implantation of venous spurs is safe and easy.
Our preliminary results were promising. Two-year iliac
venous patency has been enhanced considerably since
introduction of the method, almost reaching the
patency rates after thrombectomy of right iliac veins
and of left iliac veins without spurs. Although we con-
sider the Wallstent endoprosthesis to be superior to
others, long-term studies with different stent designs
should be undertaken to define the model best suited
for this indication.
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